HSP90AB1 and neoplasm: Several investigations have focused on the design of inhibitors with heterocyclic structures to bring down the increased level of Hsp90 proteins in cancer or tumor cells, thus providing promising treatment strategies for cancer therapy with higher targeting and efficiency/efficacy.